ArticleKidney medicine2026

Open-label Randomized Controlled Trial of Controlled-release Formulation Budesonide in Indian Proteinuric IgA Nephropathy Patients.

Pradeep Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.